What is the story behind vaccine development in COVID-19?

The outbreak of the epidemic in the first half of 2020 touched the hearts of the whole country, but now the epidemic control in China has been greatly improved. The international epidemic is getting more and more serious. COVID-19 vaccine research and development process has also been the focus of people all over the world. Finally, good news came from China on July 22nd. Zheng Zhongwei, director of the Science and Technology Development Center of the National Health and Wellness Commission, said in an interview that China officially launched the emergency use of COVID-19 vaccine on July 22nd. Up to now, according to the latest data released by the world's authoritative health organization, the total number of confirmed cases in COVID-19 has reached 23,963,653, of which 8,4851and 7 1 died. Inactivated vaccine has always been regarded as a very important weapon in the fight against virus in COVID-19.

According to the decision-making arrangements of the CPC Central Committee, the central leading group and scientific research team under the leadership of the joint prevention and control mechanism in the State Council began to lay out the task of vaccine research and development, and finally a special class for vaccine research and development was established under the scientific research team on February 15. The special category of vaccine research and development is to provide full-chain, point-to-point services for first-line scientific research. Rapid assembly has become the most advantageous scientific and technological force in China. At the same time, the protective materials, experimental animals and various experimental resources that need to be deployed urgently are sorted out to find out the most important time node of each project.

The Vaccine Management Law clearly stipulates that when a particularly serious public health incident occurs in the country, the application for emergency use of vaccines put forward by the National Health and Wellness Commission must be approved by experts from the State Pharmaceutical Administration. The main purpose is to establish an immune barrier between medical personnel and other basic personnel to ensure the operation of the city and ensure the stable operation of the whole country.

The good news from China undoubtedly gave most people a reassurance. China is also contributing China's wisdom and strength to the world.